CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Other Accumulated Expenses (2023 - 2026)

CDT Equity's (CDT) quarterly Other Accumulated Expenses came in at $786000.0 in Q1 2026, down 24.78% YoY from $1.0 million in Q1 2025, and up 46.1% on a QoQ basis from $538000.0 in Q4 2025.

CDT Equity (CDT) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

CDT Equity (CDT) has 4 years of Other Accumulated Expenses data on file, last reported at $786000.0 in Q1 2026.

  • Quarterly Other Accumulated Expenses fell 24.78% year-over-year to $786000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $786000.0 (down 24.78% YoY) and the FY2025 annual result came in at $538000.0, down 72.59% from the prior year.
  • Other Accumulated Expenses grew to $786000.0 in Q1 2026, from $538000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.0 million in Q4 2024 to a low of $538000.0 in Q4 2025.
  • A 4-year average of $1.1 million and a median of $915500.0 in 2025 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses surged 226.62% — and 2025, when it slumped 72.59%.
  • Tracing CDT's Other Accumulated Expenses over 4 years: stood at $601000.0 in 2023, then surged by 226.62% to $2.0 million in 2024, then sank by 72.59% to $538000.0 in 2025, then jumped by 46.1% to $786000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $786000.0 (Q1 2026), $538000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CDT Equity 1.55 Mn 1.55 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 802,000.00
Mar 31, 2026 786,000.00
Dec 31, 2025 538,000.00
Sep 30, 2025 1.79 Mn
Jun 30, 2025 1.14 Mn
Mar 31, 2025 1.05 Mn
Dec 31, 2024 1.96 Mn
Sep 30, 2024 1.79 Mn
Jun 30, 2024 665,000.00
Mar 31, 2024 743,000.00
Dec 31, 2023 601,000.00